Literature DB >> 11195640

The effect of eukaryotic expression vectors and adjuvants on DNA vaccines in chickens using an avian influenza model.

D L Suarez1, S Schultz-Cherry.   

Abstract

Vaccination of poultry with naked plasmid DNA has been successfully demonstrated with several different poultry pathogens, but the technology needs to be further developed before it can be practically implemented. Many different methods can conceivably enhance the efficacy of DNA vaccines, and this report examines the use of different eukaryotic expression vectors with different promoters and different adjuvants to express the influenza hemagglutinin protein. Four different promoters in five different plasmids were used to express the hemagglutinin protein of an H5 avian influenza virus, including two different immediate early cytomegaloviruses (CMVs), Rous sarcoma virus, chicken actin, and simian virus 40 promoters. All five constructs expressed detectable hemagglutinin protein in cell culture, but the pCI-neo HA plasmid with the CMV promoter provided the best response in chickens when vaccinated intramuscularly at 1 day of age on the basis of antibody titer and survivability after challenge with a highly pathogenic avian influenza virus at 6 wk postinoculation. A beneficial response was observed in birds boostered at 3 wk of age, in birds given larger amounts of DNA, and with the use of multiple injection sites to administer the vaccine. With the use of the pCI-neo construct, the effects of different adjuvants designed to increase the uptake of plasmid DNA, including 25% sucrose, diethylaminoethyl dextran, calcium phosphate, polybrene, and two different cationic liposomes, were examined. Both liposomes tested enhanced antibody titers as compared with the positive controls, but the other chemical adjuvants decreased the antibody response as compared with the control chickens that received just the plasmid alone. The results observed are promising for continued studies, but continued improvements in vaccine response and reduced costs are necessary before the technology can be commercially developed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11195640

Source DB:  PubMed          Journal:  Avian Dis        ISSN: 0005-2086            Impact factor:   1.577


  11 in total

Review 1.  Success factors for avian influenza vaccine use in poultry and potential impact at the wild bird-agricultural interface.

Authors:  David E Swayne; Erica Spackman; Mary Pantin-Jackwood
Journal:  Ecohealth       Date:  2013-09-12       Impact factor: 3.184

2.  Protective avian influenza in ovo vaccination with non-replicating human adenovirus vector.

Authors:  Haroldo Toro; De-chu C Tang; David L Suarez; Matt J Sylte; Jennifer Pfeiffer; Kent R Van Kampen
Journal:  Vaccine       Date:  2006-09-25       Impact factor: 3.641

3.  Characterization and expression of e2 glycoprotein of classical Swine Fever virus in a eukaryotic expression system.

Authors:  Barkha Ratta; Binita Nautiyal; P V Ravindra; Uttara Chaturvedi; Sudesh Kumar; P K Subudhi; Kantaraja Chindera; Sangeeta Tiwari; N N Barman; Ashok K Tiwari
Journal:  Indian J Virol       Date:  2010-09-03

4.  Avian influenza vaccination in chickens and pigs with replication-competent adenovirus-free human recombinant adenovirus 5.

Authors:  Haroldo Toro; Frederik W van Ginkel; De-Chu C Tang; Bettina Schemera; Soren Rodning; Joseph Newton
Journal:  Avian Dis       Date:  2010-03       Impact factor: 1.577

5.  Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls.

Authors:  Ron A M Fouchier; Vincent Munster; Anders Wallensten; Theo M Bestebroer; Sander Herfst; Derek Smith; Guus F Rimmelzwaan; Björn Olsen; Albert D M E Osterhaus
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

6.  Intranasal immunization with chitosan/pCAGGS-flaA nanoparticles inhibits Campylobacter jejuni in a White Leghorn model.

Authors:  Jin-lin Huang; Yan-Xin Yin; Zhi-ming Pan; Gong Zhang; Ai-ping Zhu; Xiu-fan Liu; Xin-an Jiao
Journal:  J Biomed Biotechnol       Date:  2010-08-16

7.  A single electroporation delivery of a DNA vaccine containing the hemagglutinin gene of Asian H5N1 avian influenza virus generated a protective antibody response in chickens against a North American virus strain.

Authors:  Oladele Ogunremi; John Pasick; Gary P Kobinger; Drew Hannaman; Yohannes Berhane; Alfonso Clavijo; Sylvia van Drunen Littel-van den Hurk
Journal:  Clin Vaccine Immunol       Date:  2013-01-30

8.  Development and application of reference antisera against 15 hemagglutinin subtypes of influenza virus by DNA vaccination of chickens.

Authors:  Chang-Won Lee; Dennis A Senne; David L Suarez
Journal:  Clin Vaccine Immunol       Date:  2006-03

Review 9.  DNA vaccination of poultry: The current status in 2015.

Authors:  Marine Meunier; Marianne Chemaly; Daniel Dory
Journal:  Vaccine       Date:  2015-11-25       Impact factor: 3.641

10.  DNA vaccines: improving expression of antigens.

Authors:  Helen S Garmory; Katherine A Brown; Richard W Titball
Journal:  Genet Vaccines Ther       Date:  2003-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.